.

Vinzenz Fleischer1, Tobias Brummer1, Muthuraman Muthuraman1,2

  • 1Department of Neurology, Focus Program Translational Neuroscience (FTN), Rhine Main Neuroscience Network (rmn2), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.

Frontiers in immunology
|February 17, 2025
PubMed
概括

结合MRI,OCT和血液生物标志物,可以准确预测多发性硬化症 (MS) 的残疾进展,优于单个标志物. 这种多式模式的方法提供了更全面的疾病病理学的观点,以改善患者的治疗结果.